Shots: The application is based on P-Ib/II CARTITUDE-1 study evaluating cilta-cel in adults with r/r MM who have received at least 3 prior line therapies across the US, EU, China, […]readmore
Tags : CAR-T therapy
Shots: The companies signed an agreement to ensure non-exclusive commercial access to Thermo Fisher’s Gibco CTS Dynabeads CD3/CD28 The focus of the agreement is to support clinical development & commercial […]readmore
Shots: Post FDA approval in Aug 2017, Kymriah (tisagenlecleucel, formerly CTL019) receives EU approval for treatment of patients up to 25 years with (r/r), second or later stage in B-cell […]readmore